To investigate this hypothesis, we established NASH animal models with a methionine-choline-deficient (MCD) diet and treated mice with HO-1 inducer Hemin and inhibitor ZnPP, simultaneously. The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatohepatitis.